홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Trifluoroacetohydrazide → (S)-8-Benzyl-9-((2-(trifluoromethoxy)phenyl)sulfonyl)-3-(trifluoromethyl)-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[4,3-a][1,4]diazocine

HRID 1429414
인쇄

반응식

HRID 1429414 반응식
[CH2:1]([C@@H:8]1[CH2:15][CH2:14][CH2:13][NH:12][C:11](=S)[CH2:10][N:9]1[S:17]([C:20]1[CH:25]=[CH:24][CH:23]=[CH:22][C:21]=1[O:26][C:27]([F:30])([F:29])[F:28])(=[O:19])=[O:18])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[C:31]([C:35]([NH:37][NH2:38])=O)([F:34])([F:33])[F:32].CC1C=CC(S(O)(=O)=O)=CC=1.O>C1COCC1.CCOCC.C1(C)C=CC=CC=1.O.CC(=O)OCC.[Hg](OC(C)=O)OC(C)=O>[CH2:1]([C@@H:8]1[CH2:15][CH2:14][CH2:13][N:12]2[C:35]([C:31]([F:34])([F:33])[F:32])=[N:37][N:38]=[C:11]2[CH2:10][N:9]1[S:17]([C:20]1[CH:25]=[CH:24][CH:23]=[CH:22][C:21]=1[O:26][C:27]([F:30])([F:29])[F:28])(=[O:19])=[O:18])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

9

반응물 3

HCID 229753TrifluoroacetohydrazideHCID 521998p-Toluenesulfonic acid monohydrateHCID 86677168(S)-5-Benzyl-4-((2-(trifluoromethoxy)phenyl)sulfonyl)-1,4-diazocane-2-thione

생성물 1

HCID 89414355(S)-8-Benzyl-9-((2-(trifluoromethoxy)phenyl)sulfonyl)-3-(trifluoromethyl)-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[4,3-a][1,4]diazocine수율 64.1%

시약·촉매·용매 5

HCID 16683746
Diacetyloxymercury
촉매
HCID 3283Diethyl Ether용매
HCID 8028Tetrahydrofuran용매
HCID 8857Ethyl Acetate용매
HCID 22272177Toluene water용매

실험 절차

A solution of compound 31n (150 mg, 0.33 mmol) in THF (15 mL) was cooled to 0° C., treated with Hg(OAc)2 (118 mg, 0.36 mmol) and CF3CONHNH2 (173 mg, 1.65 mmol), stirred for 2 h, diluted with Et2O (20 mL), filtered through Celite and evaporated. A solution of the residue in toluene/H2O (30:1, 15 mL) was treated with TsOH.H2O (250 mg, 1.32 mmol) and stirred at 75° C. for 12 h. The mixture was diluted with EA (30 mL) and washed with saturated K2CO3. The aqueous layer was extracted with EA (20 mL). The combined organic layers were dried over Na2SO4. After filtration, the filtrate was evaporated and the residue was purified by Preparative HPLC to give compound 31 as a white solid (113 mg, 64% yield). 1H NMR (500 MHz, CDCl3) δ 8.14 (d, J=7.5 Hz, 1H), 7.68 (t, J=8.5 Hz, 1H), 7.50 (t, J=7.5 Hz, 1H), 7.40 (d, J=8.5 Hz, 1H), 7.15-7.10 (m, 3H), 6.76-6.70 (m, 2H), 5.71 (d, J=18.0 Hz, 1H), 4.97 (m, 1H), 4.90 (d, J=8.0 Hz, 1H), 4.26 (dd, J=15.0, 8.0 Hz, 1H) 4.21 (m, 1H), 2.59 (dd, J=13.0, 10.5 Hz, 1H), 2.33 (dd, J=13.0, 5.0 Hz, 1H), 2.12-1.90 (m, 2H), 1.70-1.60 (m, 2H). MS (ESI+) m/z: 535 [M+H]+.

후처리

  1. filtrationfiltered through Celite
  2. customevaporated
  3. stirringstirred at 75° C. for 12 h
  4. washwashed with saturated K2CO3
  5. extractionThe aqueous layer was extracted with EA (20 mL)
  6. dry with materialThe combined organic layers were dried over Na2SO4
  7. filtrationAfter filtration
  8. customthe filtrate was evaporated
  9. customthe residue was purified by Preparative HPLC

출처 및 근거

ORD 기록
ord-d5a9a8fe80694e6486480c3ba25ea9e2
출처 데이터셋
uspto-grants-2015_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08940722B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트